TABLE 2.
Predictors of 1 Dose HPV Vaccine Coverage at 12 Months After Randomization: Univariate, Multivariate, and Interaction Logistic Regression Models (n = 814)
| Univariate Models | Multivariate Model | Interaction Model | |
|---|---|---|---|
| OR (95% CI) | AOR (95% CI) | AOR (95% CI) | |
| −2 Log L a | — | 1088.059 | 1081.359 |
| Study group | |||
| AC | Reference | Reference | Reference |
| I | 1.12 (0.85–1.48) | 1.11 (0.84–1.47) | 1.43 (1.02–2.02) c |
| Race/Ethnicity | |||
| Hispanic | Reference | Reference | Reference |
| Non-Hispanic black | 0.61 (0.45–0.84) b | 0.46 (0.31–0.69) b | 0.68 (0.41–1.13) |
| Non-Hispanic white | 0.99 (0.48–2.04) | 1.06 (0.50–2.23) | 1.53 (0.56–4.23) |
| Study group × race/ethnicity | |||
| Hispanic: I versus AC | — | — | 1.43 (1.02–2.02) c |
| Non-Hispanic black: I versus AC | — | — | 0.64 (0.37–1.10) |
| Non-Hispanic white I versus AC | — | — | 0.65 (0.15–2.76) |
| Age group at randomization | |||
| 11–12 y | Reference | Reference | Reference |
| 13–18 y | 0.63 (0.48–0.84) b | 0.67 (0.50–0.90) b | 0.67 (0.50–0.90) b |
| Clinic, first appointment | |||
| Clinic 1 | Reference | Reference | Reference |
| Clinic 2 | 1.06 (0.73–1.54) | 0.72 (0.47–1.12) | 0.71 (0.46–1.10) |
| Clinic 3 | 0.93 (0.66–1.32) | 0.54 (0.35–0.83) c | 0.54 (0.35–0.84) c |
| Clinic 4 | 0.93 (0.60–1.45) | 0.61 (0.36–1.01) | 0.61 (0.37–1.02) |
| Parent consented for additional contact | |||
| No consent | Reference | Reference | Reference |
| Yes, consented | 1.73 (1.30–2.29) b | 1.67 (1.25–2.23) b | 1.67 (1.25–2.24) b |
AC, active comparison; I, intervention.
Likelihood ratio test comparing multivariate and interaction models (1088.059–1081.359 = 6.7 with 10–8 = 2 DF) is significant at P = .035.
P < .01.
P < .05.